Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | CORT | STVN | ||
| Company | Cerevel Therapeutics Hldg Inc | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 44.99 | 87.23 | 21.59 | ||
| High | 44.99 | 88.73 | 22.29 | ||
| Low | 44.96 | 86.13 | 20.50 | ||
| Latest | 44.96 | 87.99 | 20.82 | ||
| Change | +0.33 | +0.86 | -0.94 | ||
| % Change | +0.74% | +0.99% | -4.32% | ||
| Volume | 15,096,300 | 1,029,100 | 376,600 | ||
| 20-Day Average Volume | 2,839,210 | 696,720 | 342,160 | ||
| Previous Close | 44.63 | 87.13 | 21.76 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 80.65 | 22.08 | ||
| 20-Day Raw Stochastic | 99.49% | 95.05% | 9.12% | ||
| 20-Day Relative Strength | 68.05 | 64.59 | 40.26 | ||
| Weighted Alpha | +49.03 | +44.91 | -13.82 | ||
| Today's Opinion | 72% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 72% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 8% Buy | 72% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +2.19% since 12/05/25 | -5.83% since 12/05/25 | ||
| Low | 43.75 on 07/25/24 | 81.31 on 12/09/25 | 20.50 on 12/12/25 | ||
| High | 44.99 on 07/31/24 | 88.73 on 12/12/25 | 22.41 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | +12.25% since 11/12/25 | -12.08% since 11/12/25 | ||
| Low | 39.16 on 07/03/24 | 73.79 on 11/18/25 | 20.50 on 12/12/25 | ||
| High | 44.99 on 07/31/24 | 88.73 on 12/12/25 | 24.01 on 11/25/25 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +20.75% since 09/12/25 | -21.20% since 09/12/25 | ||
| Low | 38.50 on 06/25/24 | 67.00 on 11/05/25 | 20.50 on 12/12/25 | ||
| High | 44.99 on 07/31/24 | 91.00 on 10/08/25 | 28.00 on 09/24/25 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +23.62% since 06/12/25 | -13.25% since 06/12/25 | ||
| Low | 38.50 on 06/25/24 | 62.40 on 08/01/25 | 20.50 on 12/12/25 | ||
| High | 44.99 on 07/31/24 | 91.00 on 10/08/25 | 28.00 on 09/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 9,165,031 | 6,589,864 | ||
| Shares Outstanding, K | 182,195 | 105,188 | 302,843 | ||
| Annual Sales | 0 | 675,040,000 | 1,194,680,000 | ||
| Annual Net Income | -432,840,000 | 141,210,000 | 127,450,000 | ||
| Last Quarter Sales | 0 | 207,640,000 | 354,370,000 | ||
| Last Quarter Net Income | -131,910,000 | 19,670,000 | 42,160,000 | ||
| 60-Month Beta | 1.40 | 0.20 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | 0.16 on 11/04/25 | 0.16 on 11/06/25 | ||
| Latest Earnings Date | 08/07/24 | 02/25/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 96.94 | 35.34 | ||